OBJECTIVE: To assess work productivity and associated factors in patients with SpA. METHODS: This cross-sectional postal survey included 1773 patients with SpA identified in a regional health care register. Items on presenteeism (reduced productivity at work, 0-100%, 0 = no reduction) were answered by 1447 individuals. Absenteeism was defined as register-based sick leave using data from a national register. Disease duration, disease activity (BASDAI), physical function (BASFI), health-related quality of life (EQ-5D), anxiety (HAD-a), depression (HAD-d), self-efficacy [Arthritis Self-efficacy Scale (ASES) pain and symptom], physical activity and education were also measured. RESULTS: Forty-five per cent reported reduced productivity at work with a mean reduction of 20% (95% CI 18, 21) and women reported a higher mean reduction than men (mean 23% vs 17%, P < 0.001). Worse quality of life, disease activity, physical function and anxiety all correlated with reduced productivity (r = 0.52-0.66, P < 0.001), while sick leave did not. Worse outcomes on the EQ-5D (β-est -9.6, P < 0.001), BASDAI (β-est 7.8, P < 0.001), BASFI (β-est 7.3, P < 0.001), ASES pain (β-est -0.5, P < 0.001) and HAD-d (β-est 3.4, P < 0.001) were associated with reduced productivity at work in patients with SpA regardless of age, gender and disease subgroup. ASES symptoms, HAD-a and education level <12 years were associated with reduced productivity but were not significant in all strata for age, gender and disease subgroup. CONCLUSION: Work productivity was reduced in patients with SpA and more so in women. Worse quality of life, disease activity, physical function, self-efficacy and depression were all associated with reduced productivity at work in patients with SpA.
OBJECTIVE: To assess work productivity and associated factors in patients with SpA. METHODS: This cross-sectional postal survey included 1773 patients with SpA identified in a regional health care register. Items on presenteeism (reduced productivity at work, 0-100%, 0 = no reduction) were answered by 1447 individuals. Absenteeism was defined as register-based sick leave using data from a national register. Disease duration, disease activity (BASDAI), physical function (BASFI), health-related quality of life (EQ-5D), anxiety (HAD-a), depression (HAD-d), self-efficacy [Arthritis Self-efficacy Scale (ASES) pain and symptom], physical activity and education were also measured. RESULTS: Forty-five per cent reported reduced productivity at work with a mean reduction of 20% (95% CI 18, 21) and women reported a higher mean reduction than men (mean 23% vs 17%, P < 0.001). Worse quality of life, disease activity, physical function and anxiety all correlated with reduced productivity (r = 0.52-0.66, P < 0.001), while sick leave did not. Worse outcomes on the EQ-5D (β-est -9.6, P < 0.001), BASDAI (β-est 7.8, P < 0.001), BASFI (β-est 7.3, P < 0.001), ASES pain (β-est -0.5, P < 0.001) and HAD-d (β-est 3.4, P < 0.001) were associated with reduced productivity at work in patients with SpA regardless of age, gender and disease subgroup. ASES symptoms, HAD-a and education level <12 years were associated with reduced productivity but were not significant in all strata for age, gender and disease subgroup. CONCLUSION: Work productivity was reduced in patients with SpA and more so in women. Worse quality of life, disease activity, physical function, self-efficacy and depression were all associated with reduced productivity at work in patients with SpA.
Entities:
Keywords:
absenteeism; patient-reported outcomes; presenteeism; spondyloarthritis; work productivity
Authors: Jorit J L Meesters; Ingemar F Petersson; Stefan Bergman; Emma Haglund; Lennart T H Jacobsson; Ann Bremander Journal: Clin Rheumatol Date: 2014-06-08 Impact factor: 2.980
Authors: Anna Jöud; Ingemar F Petersson; Kelvin P Jordan; Sofia Löfvendahl; Birgitta Grahn; Martin Englund Journal: Rheumatol Int Date: 2014-05-14 Impact factor: 2.631
Authors: Manouk de Hooge; Roberta Ramonda; Mariagrazia Lorenzin; Paola Frallonardo; Leonardo Punzi; Augusta Ortolan; Andrea Doria Journal: Arthritis Res Ther Date: 2016-11-16 Impact factor: 5.156
Authors: Marco Garrido-Cumbrera; Ottfrid Hillmann; Raj Mahapatra; David Trigos; Petra Zajc; Luisa Weiss; Galya Bostynets; Laure Gossec; Laura C Coates Journal: Rheumatol Ther Date: 2017-06-09
Authors: Lonneke van Hoeven; Annelies E R C H Boonen; Johanna M W Hazes; Angelique E A M Weel Journal: Arthritis Res Ther Date: 2017-06-17 Impact factor: 5.156